written on 22.04.2019

FT US Pharma and Biotech Summit

TAGS: USA, FT, Conference,

Securing the Future: Disrupting the Pharma Business Model

New York – 14 May 2019

The disruption which has become a feature of the pharma landscape in recent years shows no sign of slowing pace. The advent of the new wave of advanced cell and gene therapies will move pharma further in the direction of highly specialized and personalized drug development. At the same time, pharma must find a way to win in the burgeoning business of disease management, prevention and improved patient outcomes if it is to secure its place in the increasingly value-oriented healthcare world. What are the strategies pharma companies can employ to protect profitability as the competitive landscape continues to evolve?

Pharmaboardroom subscribers are entitled to a 10% discount – please use the code PHB10 when registering here.

For more information please see the event website

Contact: Email ftlive@ft.com

Tel: +44 (0)207 775 6653